Market Overview –
The fertility medicine and surgery market is anticipated to reach USD 2.21 billion by 2030, growing at a CAGR of 9.50% from 2022 to 2030.
The Fertility Drug and Surgery Market includes medications and surgical interventions aimed at treating infertility in men and women. Infertility affects millions of couples worldwide and can result from various factors, including hormonal imbalances, reproductive disorders, and lifestyle factors.
The fertility drug and surgery market is witnessing steady growth, with surgical infertility treatment playing a crucial role. As couples seek solutions for conception challenges, surgical interventions offer viable options. Procedures like laparoscopy and hysteroscopy address underlying issues such as fibroids or endometriosis, complementing fertility drugs to improve chances of successful pregnancy.
In recent years, the fertility drug and surgery market has witnessed significant growth globally due to several factors. Firstly, there has been increasing awareness of infertility and its impact on individuals and families, driving demand for fertility treatments and services. Key players in this market include pharmaceutical companies, fertility clinics, reproductive endocrinologists, and surgical centers, collaborating to develop and deliver innovative fertility solutions.
Moreover, advancements in fertility drug therapies, such as ovulation induction medications, gonadotropins, and fertility hormones, have improved treatment outcomes and success rates for couples struggling with infertility. These medications aim to stimulate ovulation, regulate hormonal imbalances, and enhance reproductive function, increasing the chances of conception.
Segment Analysis
The global fertility drug and surgery market can be segmented on the basis of drug, underlying cause, end-user, procedures, and region.
On the basis of drugs, the global fertility drug and surgery market can be segmented on the basis of clomiphene citrate, letrozole, Serophene, hormone treatment, gonadotrophins.
On the basis of the underlying cause, the global fertility drug and surgery market can be segmented on the basis of male and female
On the basis of end-user, the global fertility drug and surgery market can be segmented on the basis of fertility clinics, hospitals, clinical research institutes, and others.
On the basis of procedures, the global fertility drug and surgery market can be segmented on the basis of hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration)
On the basis of region, the global fertility drug and surgery market can be segmented on the basis of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The global fertility drugs and surgery market is dominated by the Americas – owing to increasing infertility, obesity, and delayed pregnancies. From an economic perspective, an increase in the disposable income of an average American household adds to the boost in market growth. This trend is closely followed by Europe, who stood second in 2017 in the global fertility drug and surgery market.
On the other hand, Asia Pacific happens to be the fastest-growing region for this market. It is driven by factors such as increasing awareness amongst people and growing healthcare infrastructure in this region.
Lastly, the Middle East and Africa face issues such as abject poverty and failing economics, making the market lag within this region and causing it to have the least share in this market. However, between the Middle East and Africa, the former seems to hold a bigger portion of the market share owing to increased government funding in healthcare programs and the presence of more developed economies including UAE, Kuwait, and Saudi Arabia
Key Players –
Fertility drug and surgery key players include Eli Lilly, Baxter Healthcare Corporation, Ferring Pharmaceuticals, Inc., Merck & Co. Pharmaceutical Company, Noven Pharmaceuticalorganon, Inc., Janssen Pharmaceuticals Inc., Personal Products Company, Pfizer, Inc., Procter & Gamble Pharmaceuticals, Emd Serono, Inc., and others.
Related Reports –
asia pacific aesthetics market
For more information visit at MarketResearchFuture
